Dr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an a...

Zydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat pa...

The Office of New Drugs (OND) of the US Food and Drug Administration (FDA) has denied the company's appeal of the Complete Response Letter ...

"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...

The government has identified 55 drugs that hospitals in India need to manage coronavirus patients in intensive care units.

The company informed this to the exchanges after market hours of Tuesday.

The subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.

Shares of Sun Pharma Advanced Research Company today fell by almost 3 per cent as the US health regulator has revoked its earlier approval ...

Aurobindo Pharma has received final nod from the US health regulator to make and market generic anti-epileptic Phenytoin Sodium capsules in...

Joshi points out that after the merger with Ranbaxy, the drug maker will cover all the niche area, all possible segments of the generic mar...

"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."

Glenmark Pharmaceuticals today said its US-based arm has received approval from the US health regulator to market generic Lamictal tablets.

Lupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.

Orchid Chemicals & Pharmaceuticals said it has received US FDA's approval to sell anti-epileptic levetiracetam tablets in the American mark...

Orchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...

Glenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.

Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.